The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...

The global Cardiac Biomarkers Market was valued at USD 20.8 billion in 2025 and is projected to grow from USD 23.0 billion in 2026 to USD 49.3 billion by 2033, registering a CAGR of 11.5% from 2026 to 2033. North America dominated the global market with a 43.3% revenue share in 2025, driven by the high prevalence of cardiovascular diseases (CVDs), widespread adoption of advanced...

"According to the latest report published by Data Bridge Market Research, the Glycomics Kits Market The global glycomics kits market size was valued at USD 1.35 billion in 2025 and is expected to reach USD 3.94 billion by 2033, at a CAGR of 14.35% during the forecast period A comprehensive Glycomics Kits Market research report offers better insights...

The global Microfluidics Market was valued at USD 41.9 billion in 2025 and is projected to grow from USD 46.9 billion in 2026 to USD 105.1 billion by 2033, registering a CAGR of 12.2% from 2026 to 2033. North America accounted for the largest revenue share of 42.8% in 2025, driven by the rapid adoption of microfluidic technologies across diagnostics, biomedical research, drug...

The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The United States remains a dominant force in the 2D Chromatography Market, driven by its advanced pharmaceutical and biotechnology sectors, robust research infrastructure, and strong investment in analytical technologies. The country is home to numerous leading pharmaceutical manufacturers, contract research organizations, academic research institutions, and biotechnology companies that rely...

According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...

According to a newly published market research report by 24LifeSciences, global automatic time-resolved fluorescence immunoassay analyzer market was valued at USD 850 million in 2024 and is projected to reach USD 1.65 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025–2032. Automatic time-resolved fluorescence immunoassay (TRFIA)...

 According to a newly published market research report by 24LifeSciences, global automatic time-resolved fluorescence immunoassay analyzer market was valued at USD 850 million in 2024 and is projected to reach USD 1.65 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025–2032. Automatic...